Targeting hematogenous spread of circulating tumor cells by a chemotactic drug-eluting IVC filter to prevent pulmonary and systemic metastasis

Medical Hypotheses

Volumn 74, Issue 4, 2010, Pages 668-669

  Faltas, Bishoy ^a  

^a ROCHESTER GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CANCER ANTIBODY; TUMOR ANTIGEN;

ANATOMICAL VARIATION; ANTIBODY SPECIFICITY; ARTICLE; CANCER CELL DESTRUCTION; CANCER MORTALITY; CELL ADHESION; CELL MIGRATION; CELL TRANSPORT; CYTOLYSIS; DISTANT METASTASIS; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG ELUTING INFERIOR VENA CAVA FILTER; DRUG TARGETING; HUMAN; INFERIOR CAVA VEIN; LUNG METASTASIS; METASTASIS INHIBITION; METASTASIS POTENTIAL; MORBIDITY; PRIMARY TUMOR; SECOND CANCER; SYSTEMIC CIRCULATION; SYSTEMIC DISEASE; TUMOR CELL; TUMOR VASCULARIZATION; VENA CAVA FILTER;

CELLS; CELLULAR STRUCTURES; FILTRATION; HUMANS; LUNG; NEOPLASMS; VENA CAVA FILTERS; VENA CAVA, INFERIOR;

EID: 77649342617     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.11.008     Document Type: Article

References (15)

1. Duffy M.J., McGowan P.M., and Gallagher W.M. Cancer invasion and metastasis: changing views. J Pathol 214 (2008) 283-293
2. Woodhouse E.C., Chuaqui R.F., and Liotta L.A. General mechanisms of metastasis. Cancer 80 (1997) 1529-1537
3. Morris V.L., Schmidt E.E., MacDonald I.C., Groom A.C., and Chambers A.F. Sequential steps in hematogenous metastasis of cancer cells studied by in vivo videomicroscopy. Invas Metast 17 (1997) 281-296
4. Geiger T.R., and Peeper D.S. Metastasis mechanisms. Biochim Biophys Acta 1796 (2009) 293-308
5. MacDonald I.C., Groom A.C., and Chambers A.F. Cancer spread and micrometastasis development: quantitative approaches for in vivo models. Bioessays 24 (2002) 885-893
6. Butler T.P., and Gullino P.M. Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res 35 (1975) 512-516
7. Langley R.R., and Fidler I.J. Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr Rev 28 (2007) 297-321
8. Feng X., Bao J., Jing Z., Hou J., and Gao X. Tempofilter II for tumor emboli prevention during radical nephrectomy and inferior vena cava thrombus resection for renal cell carcinoma. J Surg Oncol 100 (2009) 159-162
9. Wellons E., Rosenthal D., Schoborg T., Shuler F., and Levitt A. Renal cell carcinoma invading the inferior vena cava: use of a "temporary" vena cava filter to prevent tumor emboli during nephrectomy. Urology 63 (2004) 380-382
10. De Gregorio M.A., Gimeno M.J., Lostale F., et al. Retrievability of uncoated versus paclitaxel-coated Gunther-Tulip IVC filters in an animal model. J Vasc Interv Radiol 15 (2004) 719-726
11. Kalva S.P., Chlapoutaki C., Wicky S., Greenfield A.J., Waltman A.C., and Athanasoulis C.A. Suprarenal inferior vena cava filters: a 20-year single-center experience. J Vasc Interv Radiol 19 (2008) 1041-1047
12. Matchett W.J., Jones M.P., McFarland D.R., and Ferris E.J. Suprarenal vena caval filter placement: follow-up of four filter types in 22 patients. J Vasc Interv Radiol 9 (1998) 588-593
13. Fidler I.J., and Balch C.M. The biology of cancer metastasis and implications for therapy. Curr Probl Surg 24 (1987) 129-209
14. Fisher B., and Fisher E.R. The interrelationship of hematogenous and lymphatic tumor cell dissemination. Surg Gynecol Obstet 122 (1966) 791-798
15. del Regato J.A. Pathways of metastatic spread of malignant tumors. Semin Oncol 4 (1977) 33-38